CN102225123B - Chinese medicine for treating mammary gland foliole proliferation - Google Patents

Chinese medicine for treating mammary gland foliole proliferation Download PDF

Info

Publication number
CN102225123B
CN102225123B CN2011101734390A CN201110173439A CN102225123B CN 102225123 B CN102225123 B CN 102225123B CN 2011101734390 A CN2011101734390 A CN 2011101734390A CN 201110173439 A CN201110173439 A CN 201110173439A CN 102225123 B CN102225123 B CN 102225123B
Authority
CN
China
Prior art keywords
parts
chinese medicine
foliole
proliferation
mammary gland
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2011101734390A
Other languages
Chinese (zh)
Other versions
CN102225123A (en
Inventor
沈信堂
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2011101734390A priority Critical patent/CN102225123B/en
Publication of CN102225123A publication Critical patent/CN102225123A/en
Application granted granted Critical
Publication of CN102225123B publication Critical patent/CN102225123B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a Chinese medicine for treating mammary gland foliole proliferation. The purpose of the invention is to provide the Chinese medicine for treating mammary gland foliole proliferation, which has advantages of fast phyma dissipation, difficult relapse and good curative effect. The medicine decoction is decocted by water with the bulk drugs according to the following weight ratio: 9 to 12 parts of semiaquilegia root, 10 to 20 parts of colter straw, 9 to 12 parts of wild chrysanthemum flower, 10 to 20 parts of honeysuckle flower, 20 to 40 parts of dandelion, 9 to 12 parts of folium citrus reticulatae and 6 to 10 parts of flower bud of Japanese apricot. The present invention has the advantages that the Chinese medicine for treating mammary gland foliole proliferation has functions of clearing heat and detoxifying, detumescence and dissipating binds, coursing the liver and rectifying qi. The medicinal materials can be collected in the south of China. The invention uses a plurality of Chinese herbal medicines for a comprehensive treatment, which has the merits of obvious effect and convenient medicine taking, and the components conform to pharmaceutical administration specifications and have no toxicity or side effect on human bodies.

Description

The Chinese medicine of treatment cyclomastopathy
Technical field
The invention belongs to Chinese medicine, more specifically to the Chinese medicine of treatment cyclomastopathy.
Background technology
Cyclomastopathy betides later any age of adolescence.Pathological changes is that to sexually revise with body of gland lobule and the expansion of breast duct tip, hypertrophy and capsule be master's pathological process.Its generation is relevant with the ovary endocrine dysfunction with development, and is many because progestogen hyposecretion and estrogen are relative or definitely too much, cause the hypertrophy of mammary gland tissue in the menstrual cycle and restoration of old ways process to get muddled and fall ill.Depressed, the lonely anxiety that bad direct stimulation causes then is " catalyst " of cyclomastopathy, be more common in 25~40 years short, unmarried through rule not too, hypomenorrhea, menstrual period, do not educate or not suckling and the bad women of suckling.Though cyclomastopathy is physiological, do not need special handling can disappear voluntarily yet, like simple property cyclomastopathy, what have then is pathologic, needs active treatment, especially cystic hyperplasia type, because there is the possibility of canceration in wherein few part, can not adopt a casual attitude.Western medicine thinks that cyclomastopathy disease is relevant with ovarian dysfunction, and secretion reduces like lutein, and estrogenic secretion is increased relatively.Treatment that at present should disease has excision and oral methyl testosterone in doctor trained in Western medicine, surgical patient is painful, influences the profile of breast; Oral methyl testosterone replenishes androgen; With balance progestogen hyposecretion and hyperestrogenism, but each patient also has bigger variation at the estrogen level of different times, the difficult control of dosage; In case inappropriate medication also can be upset the balance between the human hormone, and brings side effect.The traditional Chinese medical science claims that cyclomastopathy is a nodules of the breast, thinks how to be formed by stagnation of QI due to depression of the liver, also has because of person due to the Chong and Ren channel disorder.Though the traditional Chinese medical science has many methods about treatment and alleviation cyclomastopathy that acupuncture and moxibustion therapy, oral Chinese medicine are arranged, often the long easy relapse of curative effect is treated not thorough.
Summary of the invention
The purpose of this invention is to provide the Chinese medicine that a kind of lump dissipates soon, is difficult for recurrence, eutherapeutic treatment cyclomastopathy.
The Chinese medicine of treatment cyclomastopathy of the present invention is characterized in that it is to become decoction with the following raw materials by weight proportions decocte with water: Radix Semiaquilegiae 9-12 part, Herba Violae japonicae 10-20 part, Flos Chrysanthemi Indici 9-12 part, Flos Lonicerae 10-20 part, Herba Taraxaci 20-40 part, Folium Citri tangerinae 9-12 part and flower bud of Japanese apricot 6-10 part.
The invention has the beneficial effects as follows: it has the function of heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, depressed liver-energy dispersing and QI regulating.One band all can collect all medical materials in south, and it adopts multiple Chinese herbal medicine combined therapy effect obvious, and taking convenience, each prescription are formed and met the pharmaceutical control and administration regulation, to the human non-toxic side effect.Radix Semiaquilegiae among the present invention has the merit of heat-clearing and toxic substances removing, dispersing swelling and dissipating binds.Herba Violae japonicae heat-clearing and toxic substances removing, blood stasis dispelling evacuation of pus, removing heat from blood liver heat removing cure mainly swollen ulcer drug, acute mastitis.The Flos Chrysanthemi Indici wind and heat dispersing, subduing swelling and detoxicating.Flos Lonicerae can dispelling wind-heat, also kind removing summer-heat blood poison.Folium Citri tangerinae and flower bud of Japanese apricot dispersing the stagnated live-QI to relieve the stagnation of QI, harmonizing emotions cure mainly stagnation of QI due to depression of the liver, disease such as indigestion and loss of appetite uncomfortable in chest.The traditional Chinese medical science thinks, the cyclomastopathy pathogenic factor is many to be constrained with emotion, and good sulky or irascible temperament, moving then irritability or because of damaged by excess of seven emotions are worried excessively, and are caused the liver failing to maintain the normal flow of QI, and Yu Ercheng expectorant causes phlegm-damp to be tied and gathers, coagulation of QI-blood and form lump.Therefore in the side with Radix Semiaquilegiae, Herba Violae japonicae resolving phlegm and softening hard masses, dispersing swelling and dissipating binds; With Flos Chrysanthemi Indici, Flos Lonicerae heat-clearing and toxic substances removing, the removing heat from blood dispersing swelling and dissipating binds is dredged newborn network, the dissipation carbuncle; With Folium Citri tangerinae and flower bud of Japanese apricot depressed liver-energy dispersing and QI regulating, harmonizing the functional activities of vital QI.This invention is according to respectively the distinguish the flavor of comprehensive function treatment cyclomastopathy of medicine of the mechanism utilization of morbidity.The medication process divides to take for 2-3 time for 1 dose of decocte with water every day becomes decoction according to above-mentioned prescription, each consumption 250-300ml.In clinical treatment 18 examples, subjective symptoms and sign disappear with our medicine, and lump is dissipated as recovery from illness fully, counts 11 examples; Swollen thing dwindles more than 1/2nd before the treatment, and pain disappears, and other symptoms and sign significantly are improved as produce effects, count 4 examples; Lump obviously dwindles, pain relief, other symptoms and sign have certain improvement, but tired, feelings will does not freely reach factor such as menstruation stimulate after, symptom has repeatedly for effectively, counts 2 examples; Symptom and sign all do not have obvious improver for invalid, count 1 example, and these 18 cases are being treated and followed up a case by regular visits to and all do not find malignant change in the process.
The specific embodiment
Below in conjunction with embodiment the present invention is done further description.
The crude drug title Embodiment 1 Embodiment 2 Embodiment 3 Embodiment 4 Embodiment 5
Radix Semiaquilegiae 9 parts 9 parts 11 parts 10 parts 12 parts
Herba Violae japonicae 20 parts 18 parts 16 parts 12 parts 10 parts
Flos Chrysanthemi Indici 9 parts 10 parts 12 parts 9 parts 12 parts
Flos Lonicerae 20 parts 15 parts 12 parts 18 parts 10 parts
Herba Taraxaci 20 parts 28 parts 30 parts 35 parts 40 parts
Folium Citri tangerinae 12 parts 10 parts 11 parts 10 parts 9 parts
Flower bud of Japanese apricot 10 parts 10 parts 8 parts 6 parts 7 parts
According to 1 dose of above-mentioned prescription every day, add water and decoct into decoction with conventional method, divide and take for 2-3 time, each consumption 250-300ml.

Claims (1)

1. the Chinese medicine of treatment cyclomastopathy is characterized in that it is to become decoction with the following raw materials by weight proportions decocte with water: Radix Semiaquilegiae 9-12 part, Herba Violae japonicae 10-20 part, Flos Chrysanthemi Indici 9-12 part, Flos Lonicerae 10-20 part, Herba Taraxaci 20-40 part, Folium Citri tangerinae 9-12 part and flower bud of Japanese apricot 6-10 part.
CN2011101734390A 2011-06-24 2011-06-24 Chinese medicine for treating mammary gland foliole proliferation Expired - Fee Related CN102225123B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011101734390A CN102225123B (en) 2011-06-24 2011-06-24 Chinese medicine for treating mammary gland foliole proliferation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011101734390A CN102225123B (en) 2011-06-24 2011-06-24 Chinese medicine for treating mammary gland foliole proliferation

Publications (2)

Publication Number Publication Date
CN102225123A CN102225123A (en) 2011-10-26
CN102225123B true CN102225123B (en) 2012-07-04

Family

ID=44806152

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011101734390A Expired - Fee Related CN102225123B (en) 2011-06-24 2011-06-24 Chinese medicine for treating mammary gland foliole proliferation

Country Status (1)

Country Link
CN (1) CN102225123B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103734919A (en) * 2013-12-17 2014-04-23 张月婵 Bra for curing breast pain

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101152354A (en) * 2007-09-20 2008-04-02 吴月 Traditional Chinese medicine for treating acute dacryocystitis
CN101406573A (en) * 2008-12-01 2009-04-15 季莲缘 Health-care product with toxin-expelling and health-preserving efficacy
CN101658590A (en) * 2008-08-28 2010-03-03 天津市中宝制药有限公司 Chinese medicinal paste having effect of activating blood circulation and reducing swelling
CN101856411A (en) * 2009-04-11 2010-10-13 张天良 Chinese medicament for treating mastopathy
CN101474228B (en) * 2007-12-18 2012-05-30 北京康仁堂药业有限公司 Detection method of wild chrysanthemum dispensing granule
CN101926914B (en) * 2010-08-12 2012-06-06 郑功日 Galactagog and food two-purpose instant herbal medicine for lying-in woman and preparation method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101152354A (en) * 2007-09-20 2008-04-02 吴月 Traditional Chinese medicine for treating acute dacryocystitis
CN101474228B (en) * 2007-12-18 2012-05-30 北京康仁堂药业有限公司 Detection method of wild chrysanthemum dispensing granule
CN101658590A (en) * 2008-08-28 2010-03-03 天津市中宝制药有限公司 Chinese medicinal paste having effect of activating blood circulation and reducing swelling
CN101406573A (en) * 2008-12-01 2009-04-15 季莲缘 Health-care product with toxin-expelling and health-preserving efficacy
CN101856411A (en) * 2009-04-11 2010-10-13 张天良 Chinese medicament for treating mastopathy
CN101926914B (en) * 2010-08-12 2012-06-06 郑功日 Galactagog and food two-purpose instant herbal medicine for lying-in woman and preparation method thereof

Also Published As

Publication number Publication date
CN102225123A (en) 2011-10-26

Similar Documents

Publication Publication Date Title
CN101411848B (en) Black plaster for treating gland hyperplasia and preparation method thereof
CN105288565A (en) Traditional Chinese medicine composition for treating rheumatoid bone diseases
CN101983644A (en) Medicament for treating sequelae of apoplexy
CN101721537A (en) Traditional Chinese medicine for treating rheumatic and rheumatoid arthritis
CN102225123B (en) Chinese medicine for treating mammary gland foliole proliferation
CN101703701B (en) Medicament for treating facioplegia
CN101085184A (en) Traditional Chinese medicine for treating breast cancer
CN1846781B (en) Medicine for treating chronic pharyngitis
CN103768478B (en) One is treated prostatitic Chinese medicine composition and its production and use
CN101983652A (en) Traditional Chinese medicine for treating scapulohumeral periarthritis
CN101810829B (en) Medicament for treating mastopathy
CN105327269A (en) Chinese medicine external application for treating hyperplasia of mammary glands
CN102552691B (en) External application Chinese medicinal composition for treating cystic hyperplasia of breast
CN103536745A (en) Traditional Chinese medicinal watered pills for treating hyperplasia of mammary glands
CN102552503B (en) Traditional Chinese medicine powder used for treating cervical erosion
CN101732584B (en) Throat disinhibiting bagged soaking preparation for treating pharyngitis
CN102743695B (en) Traditional Chinese medicine preparation for treating breast hyperplasia
CN102100778A (en) Traditional Chinese medicine composition for treating hyperplasia of mammary glands
CN102423386B (en) Ointment for treating hyperplasia of mammary glands
CN104524133A (en) Traditional Chinese medicinal composition for kidney tonifying, exterior strengthening and beauty treating
CN103599333B (en) A kind of external traditional Chinese medicinal application for the treatment of cervix uteri columnar epithelium dystopy
CN103356957B (en) Medicine for treating stomach cancer and preparation method thereof
CN103356926B (en) Traditional Chinese medicine preparation for treating mammary gland hyperplasia
CN1582988A (en) Wuzishan Chinese medicines for cancer pains
CN103272186A (en) Traditional Chinese medicine for curing curettage amenorrhea

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120704

Termination date: 20130624